Literature DB >> 33225395

Tumor Necrosis in Hepatocellular Carcinoma-Unfairly Overlooked?

Lana Bijelic1, Emilio Ramos Rubio2.   

Abstract

Entities:  

Year:  2020        PMID： 33225395     DOI： 10.1245/s10434-020-09402-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  2 in total

1.  Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load.

Authors:  Hua-Bang Zhou; Qiao-Mei Li; Zheng-Rong Zhong; Jing-Yi Hu; Xiao-Lan Jiang; Hao Wang; Hui Wang; Bing Yang; He-Ping Hu
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.

Authors:  Atsushi Tomioka; Tetsunosuke Shimizu; Shuji Kagota; Kohei Taniguchi; Koji Komeda; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Kazuhisa Uchiyama
Journal:  Ann Surg Oncol       Date:  2020-11-26       Impact factor: 5.344
  2 in total
  2 in total

Review 1.  The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan.

Authors:  Toshiyuki Kitai
Journal:  Surg Today       Date:  2020-11-13       Impact factor: 2.549

2.  Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population.

Authors:  Zonglin Xie; Zhenpeng Peng; Yujian Zou; Han Xiao; Bin Li; Qian Zhou; Shuling Chen; Lixia Xu; Jingxian Shen; Yunxian Mo; Sui Peng; Ming Kuang; Jianting Long; Shi-Ting Feng
Journal:  BMC Cancer       Date:  2022-06-28       Impact factor: 4.638
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.